Key result
Postprocedural high thrombus burden develops in ~66% of ACS patients with COVID-19.
Observational (n=76)
Answers are grounded in this paper and cite their sources.
Investigates the CHA2DS2-VASc score's role in predicting thrombus burden and mortality in ACS patients with COVID-19, suggesting its clinical significance.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Özen et al. (2026) conducted an observational in Acute coronary syndrome with COVID-19 (n=76). CHA2DS2-VASc score vs. Low thrombus burden (grades 1-3) vs High thrombus burden (grades 4 and 5) was evaluated on High thrombus burden (grades 4 and 5). Postprocedural high thrombus burden (grades 4-5) developed in 65.7% (50/76) of patients presenting with acute coronary syndrome and COVID-19.
Synapse has enriched 10 related papers. Consider them for comparative context: